SCHEMBL23701408

SCHEMBL23701408

CCNC(=O)N1CC2CN(c3ccc(N(C)CCCN(C)C)cc3)CC2C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
BRD4 O60885 1/20 0.34
KMT2A Q03164 3/20 0.34
MEN1 O00255 2/20 0.34
NAMPT P43490 3/20 0.34
DPP4 P27487 1/20 0.34
TSHR P16473 2/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 2/20 0.33
BCHE P06276 1/20 0.32
CACNA1B Q00975 1/20 0.32
FAAH O00519 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
ALOX12 P18054 1/20 0.32
MAPK1 P28482 1/20 0.32
MTOR P42345 1/20 0.32
RAB9A P51151 1/20 0.32
HTR2B P41595 1/20 0.32
GFER P55789 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23701406 1.00 ALDH1A1 (0.38) ALDH1A1BRD4KMT2AMEN1NAMPT
SCHEMBL23701446 0.89 ALDH1A1 (0.41) ALDH1A1KMT2AMEN1NAMPTTSHR
SCHEMBL23701447 0.89 ALDH1A1 (0.41) ALDH1A1KMT2AMEN1NAMPTTSHR
SCHEMBL23701484 0.85 CACNA1B (0.36) ALDH1A1KMT2AMEN1NAMPTTSHR
SCHEMBL27400053 0.79 GPR119 (0.46) ALDH1A1MAPT
SCHEMBL23701459 0.79 GPR119 (0.46) ALDH1A1MAPT
SCHEMBL27400026 0.78 KMT2A (0.42) ALDH1A1BRD4KMT2AMEN1DPP4
SCHEMBL23701416 0.75 CHRNB2 (0.48) ALDH1A1MAPTGFERSMN1; SMN2
SCHEMBL23701418 0.75 CHRNB2 (0.48) ALDH1A1MAPTGFERSMN1; SMN2
SCHEMBL23701363 0.74 ACACB (0.53) ALDH1A1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12018029-B2 Hexahydropyrrolo[3,4-c]pyrrole derivatives useful as LOX inhibitors THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (GB) 2024-06-25 US disclosed
US-20210238179-A1 HEXAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES USEFUL AS LOX INHIBITORS THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (GB) 2021-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12018029-B2 Hexahydropyrrolo[3,4-c]pyrrole derivatives useful as LOX inhibitors LOX, LOXL1, LOXL3 ALDH1A1 765/4885BRD4 2734/4885KMT2A 3462/4885
US-20210238179-A1 HEXAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES USEFUL AS LOX INHIBITORS LOX, LOXL1, LOXL3 ALDH1A1 765/4885BRD4 2734/4885KMT2A 3462/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.